Connect with us
The new transaction is aimed at equipping Lipogems with the necessary resources to accelerate the development of therapies for priority clinical indications, primarily knee osteoarthritis, for...
In the first half of the year alone, the sector raised $10.7 billion worldwide. Companies globally engaged in the development of gene, cellular and tissue and...
A conflict with the Food and Drug Administration did not stop Anne Wojcicki's 23andMe from giving consumers access to genetic tests.
Some of these ventures want to address issues such as hunger and unemployment.